Laura & Isaac Perlmutter Cancer Center — New York, New York

Laura & Isaac Perlmutter Cancer Center is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Laura & Isaac Perlmutter Cancer Center has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Advanced Cancer, Advanced Malignancies, Endometrial Adenocarcinoma.

Sponsors: Regeneron Pharmaceuticals, Acrivon Therapeutics, Convergent Therapeutics.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura & Isaac Perlmutter Cancer Center?

Laura & Isaac Perlmutter Cancer Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura & Isaac Perlmutter Cancer Center conducted?

Laura & Isaac Perlmutter Cancer Center has 6 clinical trials on record, with 2 currently active. Their work covers Advanced Cancer, Advanced Malignancies, Endometrial Adenocarcinoma.

Is Laura & Isaac Perlmutter Cancer Center accredited by Crixeo Health?

Laura & Isaac Perlmutter Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Laura & Isaac Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.